We included FOLR1 as a positive control since it has been shown to be highly expressed in ovarian tumors compared to healthy tissue but is decreased in platinum-resistant ovarian tumors compared to drug-sensitive tumors46,47. This evidence concerns the gene FOLR1 and ovarian neoplasm.